| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 488,446 | 8,221,000 | 7.09% | ||
| 2 | ABBVIE INC | 116,581 | 6,659,000 | 5.74% | ||
| 3 | NXSTAGE MED INC COM | 396,554 | 5,944,000 | 5.13% | ||
| 4 | VITAE PHARMACEUTICALS INC | 787,373 | 5,220,000 | 4.50% | ||
| 5 | RIGEL PHARMACEUTICAL INC | 1,876,492 | 3,903,000 | 3.37% | ||
| 6 | DERMIRA INC | 171,881 | 3,554,000 | 3.07% | ||
| 7 | INSULET CORPORATION | 106,018 | 3,516,000 | 3.03% | ||
| 8 | ALDER BIOPHARMACEUTICALS INC | 140,313 | 3,436,000 | 2.96% | ||
| 9 | MARINUS PHARMACEUTICALS INC | 566,498 | 3,048,000 | 2.63% | ||
| 10 | NEUROCRINE BIOSCIE COM USD0.001 | 76,300 | 3,018,000 | 2.60% | ||
| 11 | NOVAVAX INC COM | 553,500 | 2,856,000 | 2.46% | ||
| 12 | BIOTELEMETRY INC COM | 235,645 | 2,752,000 | 2.37% | ||
| 13 | GALAPAGOS NV | 65,568 | 2,742,000 | 2.37% | ||
| 14 | REGULUS THERAPEUTICS INC | 391,500 | 2,713,000 | 2.34% | ||
| 15 | APPLIED GENETIC TECHNOL CORP | 167,192 | 2,337,000 | 2.02% | ||
| 16 | INSULET CORP 2 06/15/2019 | 2,407,000 | 2,330,000 | 2.01% | PRN | |
| 17 | AERIE PHARMACEUTICALS INC | 179,769 | 2,186,000 | 1.89% | ||
| 18 | MASIMO CORP COM | 46,010 | 1,925,000 | 1.66% | ||
| 19 | UNIQURE NV | 158,907 | 1,888,000 | 1.63% | ||
| 20 | ACHILLION PHARMACEUTICALS INC COM | 236,500 | 1,826,000 | 1.58% | ||
| 21 | CARA THERAPEUTICS INC | 267,046 | 1,661,000 | 1.43% | ||
| 22 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,644,000 | 1.42% | PRN | |
| 23 | ISHARES TR | 6,000 | 1,565,000 | 1.35% | ||
| 24 | Stereotaxis Inc | 1,372,862 | 1,510,000 | 1.30% | ||
| 25 | BIOSPECIFICS TECHNOLOGIES CORP COM | 39,704 | 1,382,000 | 1.19% | ||
| 26 | XENON PHARMACEUTICALS INC | 193,195 | 1,350,000 | 1.16% | ||
| 27 | RADIUS HEALTH | 42,600 | 1,339,000 | 1.16% | ||
| 28 | CELYAD SA | 30,000 | 1,325,000 | 1.14% | ||
| 29 | LDR HLDG CORP COM | 50,300 | 1,282,000 | 1.11% | ||
| 30 | SPECTRANETICS CORP | 79,812 | 1,159,000 | 1.00% | ||
| 31 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,129,000 | 0.97% | ||
| 32 | DERMA SCIENCES INC COM PAR .01 | 353,718 | 1,097,000 | 0.95% | ||
| 33 | ARDELYX INC COM | 140,265 | 1,090,000 | 0.94% | ||
| 34 | LOXO ONCOLOGY INC COM | 39,000 | 1,066,000 | 0.92% | ||
| 35 | JOHNSON & JOHNSON | 9,400 | 1,017,000 | 0.88% | ||
| 36 | MACROGENICS INC | 54,200 | 1,016,000 | 0.88% | ||
| 37 | Ascendis Pharma | 53,241 | 988,000 | 0.85% | ||
| 38 | LIPOCINE INC NEW | 95,731 | 972,000 | 0.84% | ||
| 39 | MEDICINOVA INC COM NEW | 125,000 | 918,000 | 0.79% | ||
| 40 | DISCOVERY LABORATORIES INC N | 533,358 | 891,000 | 0.77% | ||
| 41 | SYNERGY PHARMACEUTICALS DEL COM NEW | 294,563 | 813,000 | 0.70% | ||
| 42 | Foamix Pharmaceuticals Ltd. | 118,671 | 774,000 | 0.67% | ||
| 43 | ALDEYRA THERAPEUTICS INC | 176,232 | 738,000 | 0.64% | ||
| 44 | ZOGENIX INC | 79,400 | 734,000 | 0.63% | ||
| 45 | AVALANCHE BIOTECHNOLOGIES IN | 140,600 | 727,000 | 0.63% | ||
| 46 | ADAPTIMMUNE THERAPEUTICS PLC | 88,100 | 716,000 | 0.62% | ||
| 47 | ADAMAS PHARMACEUTICALS INC | 47,500 | 687,000 | 0.59% | ||
| 48 | CAREDX INC | 136,047 | 675,000 | 0.58% | ||
| 49 | TOBIRA THERAPEUTICS INC | 81,402 | 666,000 | 0.57% | ||
| 50 | ESSA Pharma | 202,496 | 662,000 | 0.57% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000029, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
